Sudarshan Sukhani of s2analytics.com suggest one can buy pharma stocks.

Buy Ranbaxy Labs; target of Rs 575: Panda

Jitendra Panda, Future Capital is of the view that one can buy Ranbaxy Laboratories at current levels with a target of Rs 575.

Ranbaxy Laboratories may rally to Rs 565, says Bothra

Kunal Bothra of LKP is of the view that, if Ranbaxy Laboratories manages to hold Rs 540, from a trading perspective one can look at a target of Rs 565 and even Rs 570 and above from the current levels.

Sun Pharma, Ranbaxy in strong uptrend: Sukhani

Sun Pharma and Ranbaxy are indicating strong uptrend, says Sudarshan Sukhani, s2analytics.com.

Super Six: Kulkarni, Jadeja, Agarwal on their top picks

On CNBC-TV18's show Super Six, market gurus Shardul Kulkarni of Angel Broking, Vikrant Jadeja of Vibrant Trades and Rajeev Agarwal of dynamixresearch.in, place their bets on two stocks each, thus offering investors a variety of options to choose from.

Short Ranbaxy Laboratories: Rikesh Parikh

Rikesh Parikh, Motilal Oswal Financial Services is of the view that one can short Ranbaxy Laboratories and keep Rs 543 as a stop loss. It can come down to around Rs 500-510 levels.

Super six stocks for trade today

On CNBC-TV18's show Super Six, market gurus Shardul Kulkarni of Angel Broking, Manav Chopra of Nirmal Bang and Rajesh Jain of Religare Securities, place their bets on two stocks each, thus offering investors a variety of options to choose from.

Buy Ranbaxy Laboratories: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com is of the opinion that one can buy Ranbaxy Laboratories.

Buy Ranbaxy Laboratories: Mehta

Dipesh Mehta, Nirmal Bang Securities is of the view that one can buy Ranbaxy Laboratories.

Ranbaxy Laboratories may rally to Rs 565, says Kulkarni

Shardul Kulkarni, Sr.Technical Analyst, Angel Broking is of the view that, Ranbaxy Laboratories' chart is quite bullish and it may rally to Rs 565.

Super Six trading ideas for the day

On CNBC-TV18's show Super Six, market gurus Shardul Kulkarni of Angel Broking, Vishal Kshatriya of Edelweiss and Rajesh Jain of Religare Securities, place their bets on two stocks each, thus offering investors a variety of options to choose from.

Buy Ranbaxy Labs around Rs 540: Mohindar

Rahul Mohindar, viratechindia.com advice traders to buy Ranbaxy Labs around Rs 540.

Ranbaxy Labs top pick in pharma space, says Kulkarni

Shardul Kulkarni, Angel Broking is of the view that, Ranbaxy Laboratories is looking strong in pharma space, which is having target of Rs 575-580.

SP Tulsian positive on Lupin, Ranbaxy Labs

SP Tulsian, sptulsian.com is positive on Lupin, Ranbaxy Labs. IFCI may settle around Rs 25- 26.

Pension, pharma reforms vital; realty to rally on: Tulsian

Stock analyst SP Tulsian of sptulsian.com explains to CNBC-TV18 that, in his view, the reforms in pension and pharma, listed on the agenda for the Cabinet meet on Thursday evening, were vital for the health of the market and the economy.

Buy Ranbaxy Labs; target of Rs 570-580: Sukhani

Sudarshan Sukhani, s2analytics.com is of the view that one can buy Ranbaxy Laboratories with a target of Rs 570-580.

Check out: Super Six stocks for September 27

On CNBC-TV18's show Super Six, market gurus Manas Jaiswal, manasjaiswal.com, Manav Chopra, Nirmal Bang and Rajesh Jain, Religare Sec, place their bets on two stocks each, thus offering investors a variety of options to choose from.

Hero Motocorp has target of Rs 2000: Sukhani

Hero Motocorp has target of Rs 2000, says Sudarshan Sukhani of s2analytics.com. The stock is now making a very decent bullish pattern. It is one of the better stocks in the universe among the blue-chips also.

Nifty may not fall below 5350; selective on infra: Tulsian

SP Tulsian, of sptulsian.com, says that he expect the Nifty to not fall below 5350 level. Bank Nifty has reached a level of 11400-11500. Bank Nifty can again fall to a low of 10200 as Bank Nifty is exhibiting the maximum activity.

Short Ranbaxy, Dena Bank: Saurabh Mittal

In CNBC-TV18's popular show Bull's Eye, Saurabh Mittal, Swadeshi Credits shares trading strategy of the day.

Short Ranbaxy Laboratories, says Sukhani

Short Ranbaxy Laboratories, says Sudarshan Sukhani of s2analytics.com. It has made a small but fairly strong bearish pattern. It has broken down from that.

Bull's eye: Buy KFA, Lanco, short Jet Airways, Ranbaxy

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Avoid Reliance Infra; sell Ranbaxy Labs: Sukhani

Sudarshan Sukhani, s2analytics.com advice traders to avoid Reliance Infra and sell Ranbaxy Labs.

Sukhani upbeat on banking sector

Sudarshan Sukhani of s2analytics.com is upbeat on banking sector. He also add that one should get out of Ranbaxy Laboratories, that‘s having a very poor chart in the current context.

Buy Ranbaxy Laboratories 580 Call: VK Sharma

Buy Ranbaxy Laboratories 580 Call at Rs 12, says VK Sharma of HDFC Securities. We have had a 38% rise in open interest. The stock has gone up 4% over the last three days.